Skip to main content
Search
Slovenia
|
en
Choose Location
Slovenia
|
English
Slovenian
Americas
Asia Pacific
Europe
International
Middle East & Africa
Argentina |
es
Brazil |
pt
Canada |
en
Canada |
fr
Central America |
es
Colombia |
es
Latin America |
es
Mexico |
es
United States |
en
Venezuela |
es
Australia |
en
Hong Kong S.A.R. |
zh
India |
en
Indonesia |
en
Japan |
ja
Korea |
ko
Mainland China |
zh
Malaysia |
en
Philippines |
en
Singapore |
en
Taiwan |
zh
Austria |
de
Belgium |
fr
Belgium |
nl
Bulgaria |
bg
Czech Republic |
cs
Czech Republic |
en
Denmark |
da
Estonia |
et
Finland |
fi
France |
fr
Germany |
de
Greece |
el
Hungary |
hu
Ireland |
en
Israel |
he
Italy |
it
Latvia |
lv
Lithuania |
lt
Netherlands |
nl
Norway |
no
Poland |
pl
Portugal |
pt
Romania |
ro
Russia |
ru
Serbia |
sr
Slovakia |
sk
Slovenia |
sl
Slovenia |
en
Spain |
es
Sweden |
sv
Switzerland |
de
Switzerland |
fr
Ukraine |
uk
United Kingdom |
en
Novartis |
en
Novartis Foundation |
English
Egypt |
en
South Africa |
en
Turkey |
tr
si
Choose Location
Slovenia
English
Slovenian
europe
Americas
Asia Pacific
Europe
International
Middle East & Africa
Argentina |
es
Australia |
en
Austria |
de
Belgium |
fr
Belgium |
nl
Brazil |
pt
Bulgaria |
bg
Canada |
en
Canada |
fr
Central America |
es
Colombia |
es
Czech Republic |
cs
Czech Republic |
en
Denmark |
da
Egypt |
en
Estonia |
et
Finland |
fi
France |
fr
Germany |
de
Greece |
el
Hong Kong S.A.R. |
zh
Hungary |
hu
India |
en
Indonesia |
en
Ireland |
en
Israel |
he
Italy |
it
Japan |
ja
Korea |
ko
Latin America |
es
Latvia |
lv
Lithuania |
lt
Mainland China |
zh
Malaysia |
en
Mexico |
es
Netherlands |
nl
Norway |
no
Novartis |
en
Novartis Foundation |
English
Philippines |
en
Poland |
pl
Portugal |
pt
Romania |
ro
Russia |
ru
Serbia |
sr
Singapore |
en
Slovakia |
sk
Slovenia |
sl
Slovenia |
en
South Africa |
en
Spain |
es
Sweden |
sv
Switzerland |
de
Switzerland |
fr
Taiwan |
zh
Turkey |
tr
Ukraine |
uk
United Kingdom |
en
United States |
en
Venezuela |
es
Menu
About
Novartis in Slovenia
Country Leadership Team
Strategy
Diversity, Equity and Inclusion
People and culture
Products
Contacts
About
Patients and Caregivers
Novartis Commitment to Patients and Caregivers
Adverse Event Reporting
Diseases
Products
Patients and Caregivers
Healthcare Professionals
Healthcare professional country resource
Products
Pipeline
Adverse Event Reporting
Clinical studies
Healthcare Professionals
ESG
Ethics, risk and compliance
Access
Environmental Sustainability
Global Health
Ethical Behavior
Reporting
ESG
Media
News Archive
Stories
Media Contact
Media
Careers
Careers at Novartis in Slovenia
University & Secondary school students
How We Work
Wellbeing
Diversity, Equity and Inclusion
Meet the teams
Personal Growth
Early Talent
Awards and Recognition
Careers
Development and production of innovative medicines
BioCamp
Home
Site Search
Global Search Navigation
All
Site Pages
Media Releases
Access to Healthcare
Careers
Emerging Technology
People and Culture
Reimagine Medicine
Scientific Research
Social Commitment
Women in Science
Working at Novartis
Sort by
Relevance
Newest first
Oldest first
- Any -
Media Library
In The News
Interior Page
Media Release
Featured News
Story
Hide Filters
Showing 23 results
Ethics, risk and compliance
Reporting
Novartis in Slovenia
Careers
Strategy
Access
Novartis Commitment to Patients and Caregivers
News Archive
Country Leadership Team
Privacy Policy
Pagination
‹
Previous page
1
2
3
›
Next page
News Archive Navigation Language
Language
English
French
German
Sorodne novice
Novartis marks new investment in high-tech BioCampus in Mengeš